Provider

The acquisition expands Teladoc's specialist network and presence in the region, while the company navigates ongoing financial challenges.

ArteraAI Prostate uses digital pathology images from a patient’s biopsy to predict potential long-term outcomes of their prostate cancer.

The companies will develop AI models trained on real-world data to help identify and diagnose patients with paroxysmal nocturnal hemoglobinuria.

Dr. Hojjat Salmasian, CDAO and leader of AI at Children's Hospital of Philadelphia, discusses the first steps toward an AI strategy for hospitals and health systems as well as the key elements needed.

The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combating the FDA’s claim that it qualifies as a regulated medical device.

Kenrick Cato, nurse scientist, pediatric data and analytics, Children's Hospital of Philadelphia, says that nurses are excited about AI but are cautious and while they want help from AI, they don't want AI to do their job.

The feature will be available via new iOS and watchOS updates, one year after the U.S. International Trade Commission banned Apple from selling its Series 9, Series 10 and Ultra 2 watches.

The company will use the funds to expand its technology offerings and nationwide partnerships.

Megan Zakrewsky, VP of product for clinical data exchange at Veradigm, discusses how automating payer data exchange and reducing desktop crowding for providers supports decision-making and reduce burnout.

Data from Dexcom CGMs will be integrated into FriskaAi and will be monitored by AI-powered algorithms that alert patients when action is advised.